Fructose and sugar: A major mediator of non-alcoholic fatty liver disease T Jensen, MF Abdelmalek, S Sullivan, KJ Nadeau, M Green, C Roncal, ... Journal of hepatology 68 (5), 1063-1075, 2018 | 904 | 2018 |
Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation RJ Johnson, GL Bakris, C Borghi, MB Chonchol, D Feldman, MA Lanaspa, ... American Journal of Kidney Diseases 71 (6), 851-865, 2018 | 501 | 2018 |
Antithrombotic therapy for atrial fibrillation with stable coronary disease S Yasuda, K Kaikita, M Akao, J Ako, T Matoba, M Nakamura, K Miyauchi, ... New England Journal of Medicine 381 (12), 1103-1113, 2019 | 430 | 2019 |
Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial K Kimura, T Hosoya, S Uchida, M Inaba, H Makino, S Maruyama, S Ito, ... American Journal of Kidney Diseases 72 (6), 798-810, 2018 | 325 | 2018 |
High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism MA Lanaspa, M Kuwabara, A Andres-Hernando, N Li, C Cicerchi, ... Proceedings of the National Academy of Sciences 115 (12), 3138-3143, 2018 | 254 | 2018 |
Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese cohort study M Kuwabara, I Hisatome, K Niwa, S Hara, CA Roncal-Jimenez, ... Hypertension 71 (1), 78-86, 2018 | 243 | 2018 |
Hyperuricemia, cardiovascular disease, and hypertension M Kuwabara Pulse 3 (3-4), 242-252, 2016 | 225 | 2016 |
Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: five-year Japanese cohort study M Kuwabara, K Niwa, I Hisatome, T Nakagawa, CA Roncal-Jimenez, ... Hypertension 69 (6), 1036-1044, 2017 | 220 | 2017 |
Ezetimibe lipid-lowering trial on prevention of atherosclerotic cardiovascular disease in 75 or older (ewtopia 75) A randomized, controlled trial Y Ouchi, J Sasaki, H Arai, K Yokote, K Harada, Y Katayama, T Urabe, ... Circulation 140 (12), 992-1003, 2019 | 184 | 2019 |
Different risk for hypertension, diabetes, dyslipidemia, and hyperuricemia according to level of body mass index in Japanese and American subjects M Kuwabara, R Kuwabara, K Niwa, I Hisatome, G Smits, ... Nutrients 10 (8), 1011, 2018 | 177 | 2018 |
Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension M Kuwabara, K Niwa, Y Nishi, A Mizuno, T Asano, K Masuda, I Komatsu, ... Hypertension Research 37 (8), 785-789, 2014 | 162 | 2014 |
Disorders of lipid metabolism in chronic kidney disease MC Bulbul, T Dagel, B Afsar, NN Ulusu, M Kuwabara, A Covic, M Kanbay Blood purification 46 (2), 144-152, 2018 | 160 | 2018 |
Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017-2018 R Ae, N Makino, K Kosami, M Kuwabara, Y Matsubara, Y Nakamura The Journal of pediatrics 225, 23-29. e2, 2020 | 156 | 2020 |
Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan M Kuwabara, C Borghi, AFG Cicero, I Hisatome, K Niwa, M Ohno, ... International journal of cardiology 261, 183-188, 2018 | 149 | 2018 |
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD Y Sato, DI Feig, AG Stack, DH Kang, MA Lanaspa, AA Ejaz, ... Nature Reviews Nephrology 15 (12), 767-775, 2019 | 147 | 2019 |
Depletion of uric acid due to SLC22A12 (URAT1) loss-of-function mutation causes endothelial dysfunction in hypouricemia S Sugihara, I Hisatome, M Kuwabara, K Niwa, N Maharani, M Kato, ... Circulation Journal 79 (5), 1125-1132, 2015 | 119 | 2015 |
Hyperuricemia is an independent competing risk factor for atrial fibrillation M Kuwabara, K Niwa, S Nishihara, Y Nishi, O Takahashi, K Kario, ... International journal of cardiology 231, 137-142, 2017 | 117 | 2017 |
Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats LG Sanchez-Lozada, A Andres-Hernando, FE Garcia-Arroyo, C Cicerchi, ... Journal of Biological Chemistry 294 (11), 4272-4281, 2019 | 116 | 2019 |
Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice MA Lanaspa, A Andres-Hernando, DJ Orlicky, C Cicerchi, C Jang, N Li, ... The Journal of clinical investigation 128 (6), 2226-2238, 2018 | 104 | 2018 |
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout D Bursill, WJ Taylor, R Terkeltaub, A Abhishek, AK So, AB Vargas-Santos, ... Annals of the rheumatic diseases 78 (11), 1592-1600, 2019 | 100 | 2019 |